Table II.
Comparison of Two Independent PKCθ Knockout Strains
Sun et al. (reference 14) | This study | |
---|---|---|
Targeting strategy: | Exon 11 replaced by PKG-neo | Cre/loxP null allele (deletion of exons 3 and 4) |
Residual open reading frame | 365 aa | 9 aa |
Thymocytes: | ||
Development | normal | normal |
Peripheral T cells: | ||
Proliferative responses | ||
to CD3/CD28 | impaired | impaired |
to PMA/ionomycin | impaired | normal |
to allogenic MHC | partially impaired | partially impaired |
IL-2 production | ||
to CD3/CD28 | impaired | impaired |
to PMA/ionomycin | impaired | normal |
Heterozygous phenotype: | impaired | normal |
EMSA/stimulated with CD3/CD28 | ||
NF-κB | impaired | partially impaired |
AP-1 | impaired | partially impaired |
NFAT | normal | impaired |
Surface expression/stimulated with CD3/CD28 | ||
CD69 | impaired | normal |
CD25 | impaired | normal |